Magic mushroom compound may rebuild brain synapses in early memory loss
NCT ID NCT06041152
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study is testing whether psilocybin, the active ingredient in magic mushrooms, can increase the density of synapses (connections between brain cells) in people with mild memory problems. Ten participants—six with amnestic mild cognitive impairment and four healthy volunteers—will receive either two doses of psilocybin or a placebo. Researchers will use brain scans to measure changes in synapse density and check if any changes are linked to better thinking and memory.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
psilocybin
What this could lead to
If it works, this could point toward a new way to treat or slow memory decline in early Alzheimer's by boosting brain connections.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply widely. It's designed to measure brain changes, not to prove a treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMNESTIC MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M5T 1R8, Canada